Psoriasis Archives - JDDonline - Journal of Drugs in Dermatology

Aug 07

Journal of Drugs in Dermatology JDD Article About Deucravacitinib With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

Deucravacitinib With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

By Nadia Marcus Featured Articles, Latest News, Psoriasis, The Latest

Boosting Psoriasis Outcomes with a Dual Strategy - Deucravacitinib Plus Calcipotriene/Betamethasone Foam Shows Lasting Benefits A promising new open-label study in our August issue highlights how adding topical calcipotriene/betamethasone dipropionate…

Jul 19

Love2

Journal of Drugs in Dermatology JDD Article About Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis

Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis

By Nadia Marcus Featured Articles, Latest News, Psoriasis, The Latest

Can Probiotics Help Psoriasis? This Study Says Yes—And Here’s Why You Should Pay Attention Could your next psoriasis treatment plan include probiotics? A randomized, double-blind, placebo-controlled trial published in JDD’s June…

Apr 29

Love4

Looking for Curated Psoriasis Content? We’ve Got You Covered!

By Nadia Marcus Featured Articles, Latest News, Psoriasis, The Latest

Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on psoriasis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking for…

Mar 27

Love0

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

By Nadia Marcus Featured Articles, Latest News, Psoriasis, The Latest

Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…

Feb 28

Love0

What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow your roll you say? The paradigm shift has occurred and for many of our established patients it’s now about cleaning up the biologic leftovers, especially when located on far reaching and sensitive sites. How to do so? So glad you asked, as we are so fortunate Dr. Peter Lio, clinical assistant professor of dermatology and pediatrics at Northwestern, joined host Dr. Adam Friedman to provide his experiences to pick apart the NYC diner menu of topical option add-ons to our powerful buffet of advanced systemics. Make sure to come hungry!

Pspecial Psite Psoriasis Pearls: Picking the Right Combo Meal for your Patients

By Nadia Marcus Featured Articles, Featured Podcast, Podcast Highlights, Psoriasis, The Latest

Featured Podcast What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow…

Feb 14

Love1

Journal of Drugs in Dermatology JDD Article About Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone elbow with psoriasis.

Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses

By Nadia Marcus Featured Articles, JDD Highlights, Latest News, Psoriasis, The Latest

JDD Spotlight: Guselkumab's 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…

Feb 10

Love0

Journal of Drugs in Dermatology JDD in partnership with George Washington University presents a new installment of Transitional Science Lecture Series.

Translational Science Lecture Series

By Nadia Marcus Latest News, Psoriasis, The Latest

PSO Exciting: Clinical Pearls and Emerging Therapies For Psoriasis The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As…

Jan 08

Love0

JDD video abstract on what makes some IL-23 Biologics More Effective in Psoriasis featuring Christopher G. Bunick MD, PhD

Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis

By Nadia Marcus Psoriasis, The Latest, Video Pearls

Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis Check our all-new video abstract from Christopher G. Bunick MD PhD, who gives structural insights into what makes some…

Sep 19

Love8

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

By Matt Breeman Acne, Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Psoriasis, Skin of Color, The Latest

by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…

Aug 26

Love1

Journal of Drugs in Dermatology JDD article about recalcitrant erythrodermic psoriasis complicated by septic shock and mycotic aneurysm: a call for treatment guidelines

Recalcitrant Erythrodermic Psoriasis Complicated by Septic Shock and Mycotic Aneurysm: A Call for Treatment Guidelines

By Krista Reznik Featured Articles, Psoriasis, The Latest

JDD Article Highlight Erythrodermic psoriasis is a severe condition with life-threatening complications, including infection and cardiovascular issues. In the JDD article titled "Recalcitrant Erythrodermic Psoriasis Complicated by Septic Shock and Mycotic…

Jun 22

Love8

Dermatology Roundup: Study Explains What Drives Psoriasis Severity, HS Docuseries Premieres

By Krista Reznik Dermatology Roundup, JDD Highlights, JDD in the Media, Psoriasis, Skin Cancer, The Latest

By Allison Sit Researchers from NYU Grossman School of Medicine have determined what may drive psoriasis severity and how the disease impacts the rest of the body. The study, published…

May 22

Love0

Psoriasis Therapy and Infection: Realities and Myths

By Krista Reznik Psoriasis, Video Pearls

Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Ted Rosen, professor of dermatology at Baylor College of Medicine…

NextPrevious »

Psoriasis

Deucravacitinib With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis

Looking for Curated Psoriasis Content? We’ve Got You Covered!

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

Pspecial Psite Psoriasis Pearls: Picking the Right Combo Meal for your Patients

Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses

Translational Science Lecture Series

Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

Recalcitrant Erythrodermic Psoriasis Complicated by Septic Shock and Mycotic Aneurysm: A Call for Treatment Guidelines

Dermatology Roundup: Study Explains What Drives Psoriasis Severity, HS Docuseries Premieres

Psoriasis Therapy and Infection: Realities and Myths

Advertisement

Dermatology Topics

Advertisement

Top News Stories

News Topics

Journal of Drugs in Dermatology

Search